Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Daily News

Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In

Yael L. Maxwell

November 10, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Michael O'Riordan

September 13, 2016

News Daily News

Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns

Todd Neale

September 12, 2016

News Daily News

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Michael O'Riordan

August 23, 2016

News Daily News

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Michael O'Riordan

August 16, 2016

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Daily News

USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals

Michael O'Riordan

April 12, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Daily News

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

Todd Neale

February 25, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Daily News

Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI

Todd Neale

December 10, 2015

News Daily News

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Michael O'Riordan

December 02, 2015

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Conference News AHA 2015

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

Shelley Wood

November 08, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Industry News

FDA approves Repatha to treat certain patients with high cholesterol

August 28, 2015

Advertisement

Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Review Touts Benefits of Statins, Seeks to Dispel Safety Concerns

Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

FDA approves Repatha to treat certain patients with high cholesterol

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content